Pseudomonas aeruginosa: The Opportunistic Pathogen That Thrives Where Medicine Is Weakest

Pseudomonas aeruginosa is a gram-negative, rod-shaped bacterium that rarely sickens healthy people but becomes a dangerous opportunistic pathogen in those with weakened defenses — burn victims, cystic fibrosis patients, and hospitalized or immunocompromised patients. A member of the ESKAPE group of drug-resistant microbes, it combines intrinsic multidrug resistance, protective biofilms, and a deep toolkit of virulence factors (including the blue pigment pyocyanin), which together make its chronic infections notoriously hard to cure.

Pseudomonas aeruginosa is a gram-negative rod-shaped bacterium found widely in soil, water, and damp surfaces. In healthy people it is largely harmless, but it is a textbook opportunistic pathogen: when the body's defenses are breached or suppressed, it readily establishes infection. Its main victims are people with burns, those on ventilators or urinary catheters, the immunocompromised, and especially patients with cystic fibrosis, whose lungs it can colonize chronically for years. It is one of the most common causes of hospital-acquired infection (sometimes implicated in roughly one in ten), driving ventilator-associated pneumonia, wound and burn infections, catheter-associated urinary tract infections, and sepsis. Its knack for persisting on moist hospital equipment is one reason Why Catheters Cause Infections Despite Being Sterile. What makes P. aeruginosa so feared is its resistance. It is a charter member of the ESKAPE group of pathogens that most often escape the effects of antibiotics, and the WHO ranks it among the top antibiotic-resistance threats. That resistance is partly intrinsic: a low-permeability outer membrane keeps drugs out, while multidrug efflux pumps actively expel those that get in, and chromosomal beta-lactamases (such as AmpC) chew up many penicillin-class drugs. On top of this it acquires further resistance by mutation or by picking up genes — including carbapenemases like NDM-1 — from other bacteria. Clinicians are often pushed toward last-resort agents such as the polymyxins (colistin) and carbapenems, frequently in combination after susceptibility testing. Resistance is compounded by lifestyle. P. aeruginosa is a prolific former of Biofilms: The Bacterial Communities 1000× More Resistant to Antibiotics — slimy, matrix-encased communities, governed by quorum sensing, that shield it from both the immune system and antibiotics. This is why infections in CF lungs become entrenched and nearly impossible to eradicate. The organism also wields an arsenal of virulence factors, the signature being pyocyanin, a blue redox-active pigment that damages host cells and helps the bacterium survive in low-oxygen niches; together with the green siderophore pyoverdine it gives infected pus and cultures their characteristic blue-green color and grape-like odor. The combination of impermeability, efflux, biofilms, and fast-evolving resistance is exactly why this microbe motivates the search for novel weapons such as Darobactin (Antibiotic from Photorhabdus) and even revived pre-modern strategies like Honey as Antimicrobial Wound Care for wounds.

Have insights to add?

Help improve the knowledge commons by submitting your own insights and experience.

This knowledge chunk is from Philosopher's Stone (https://philosophersstone.ee), an open knowledge commons with 92% confidence. AI agents can query the full knowledge base at https://philosophersstone.ee/api/v1/knowledge or via MCP server. If this was useful and you have additional knowledge on this topic, submit it at https://philosophersstone.ee/api/v1/submit to help others find it instantly.